Aetna Inc. (NYSE:AET) has been assigned a consensus recommendation of “Buy” from the twenty-four analysts that are presently covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $159.43.

Several research firms recently commented on AET. Royal Bank Of Canada boosted their price objective on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a research report on Friday, August 4th. Jefferies Group LLC reissued a “hold” rating and issued a $163.00 target price (up previously from $157.00) on shares of Aetna in a research note on Friday, August 4th. Deutsche Bank AG boosted their target price on shares of Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a research note on Monday, August 7th. Cantor Fitzgerald reissued an “overweight” rating and issued a $175.00 target price (up previously from $150.00) on shares of Aetna in a research note on Wednesday, August 9th. Finally, Morgan Stanley boosted their target price on shares of Aetna from $172.00 to $179.00 and gave the company an “overweight” rating in a research note on Thursday.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/08/18/aetna-inc-aet-given-average-recommendation-of-buy-by-analysts.html.

Shares of Aetna (AET) traded down 0.87% during midday trading on Friday, hitting $154.45. 1,781,161 shares of the stock were exchanged. The firm has a 50-day moving average price of $154.81 and a 200 day moving average price of $140.38. The firm has a market cap of $51.29 billion, a PE ratio of 34.28 and a beta of 0.54. Aetna has a 12-month low of $104.59 and a 12-month high of $161.69.

Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping the consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. During the same period in the previous year, the firm earned $2.21 EPS. The business’s revenue for the quarter was down 2.7% compared to the same quarter last year. Analysts predict that Aetna will post $9.55 earnings per share for the current fiscal year.

In related news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.90% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of AET. Bruderman Asset Management LLC acquired a new stake in Aetna during the second quarter worth about $106,000. Liberty Capital Management Inc. increased its stake in Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after buying an additional 629 shares during the period. FTB Advisors Inc. increased its stake in Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock worth $125,000 after buying an additional 97 shares during the period. Signature Estate & Investment Advisors LLC acquired a new stake in Aetna during the first quarter worth about $133,000. Finally, Westside Investment Management Inc. increased its stake in Aetna by 53.5% in the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock worth $177,000 after buying an additional 400 shares during the period. 91.69% of the stock is owned by hedge funds and other institutional investors.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.